TP53 and malignant colon neoplasm: The present study is the first to identify that ilimaquinone and ethylsmenoquinone from a marine sponge drive the accumulation of the p53 protein, thereby activating the p53 signaling pathway and efficiently inhibiting the growth of human colon cancer cells in the absence of TRAIL.